mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Radical Autoxidation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 27, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Alan R Oyler1, Barbara L Armstrong, Richard Dunphy
1University of Minnesota Duluth, Duluth, MN 55812, USA. aoyler@d.umn.edu
Rapamycin, an immunosuppressant, degrades into many products, complicating analysis. A validated mass balance method using SEC and RP-HPLC effectively tracks drug loss and product formation in drug-eluting stents.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: